Literature DB >> 17133207

Practical and conceptual challenges in measuring antiretroviral adherence.

Karina M Berg1, Julia H Arnsten.   

Abstract

Accurate measurement of antiretroviral adherence is essential for targeting and rigorously evaluating interventions to improve adherence and prevent viral resistance. Across diseases, medication adherence is an individual, complex, and dynamic human behavior that presents unique measurement challenges. Measurement of medication adherence is further complicated by the diversity of available measures, which have different utility in clinical and research settings. Limited understanding of how to optimize existing adherence measures has hindered progress in adherence research in HIV and other diseases. Although self-report is the most widely used adherence measure and the most promising for use in clinical care and resource-limited settings, adherence researchers have yet to develop evidence-based standards for self-reported adherence. In addition, the use of objective measures, such as electronic drug monitoring or pill counts, is limited by poor understanding of the source and magnitude of error biasing these measures. To address these limitations, research is needed to evaluate methods of combining information from different measures. The goals of this review are to describe the state of the science of adherence measurement, to discuss the advantages and disadvantages of common adherence measurement methods, and to recommend directions for improving antiretroviral adherence measurement in research and clinical care.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17133207      PMCID: PMC2866146          DOI: 10.1097/01.qai.0000248337.97814.66

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  85 in total

1.  Conducting cognitive interviews to understand question-response limitations.

Authors:  Kristen Miller
Journal:  Am J Health Behav       Date:  2003 Nov-Dec

2.  Antiretroviral concentrations in untimed plasma samples predict therapy outcome in a population with advanced disease.

Authors:  Christopher S Alexander; Jérôme J Asselin; Lillian S L Ting; Julio S G Montaner; Robert S Hogg; Benita Yip; Michael V O'Shaughnessy; P Richard Harrigan
Journal:  J Infect Dis       Date:  2003-07-29       Impact factor: 5.226

3.  Disease progression, adherence, and response to protease inhibitor therapy for HIV infection in an Urban Veterans Affairs Medical Center.

Authors:  K Maher; N Klimas; M A Fletcher; V Cohen; C M Maggio; J Triplett; R Valenzuela; G Dickinson
Journal:  J Acquir Immune Defic Syndr       Date:  1999-12-01       Impact factor: 3.731

4.  Assessing medication adherence in adolescents with HIV when electronic monitoring is not feasible.

Authors:  Lori Wiener; Kristin Riekert; Celia Ryder; Lauren V Wood
Journal:  AIDS Patient Care STDS       Date:  2004-09       Impact factor: 5.078

5.  Patient-clinician relationships and treatment system effects on HIV medication adherence.

Authors:  Karen S Ingersoll; Carolyn J Heckman
Journal:  AIDS Behav       Date:  2005-03

6.  How often is medication taken as prescribed? A novel assessment technique.

Authors:  J A Cramer; R H Mattson; M L Prevey; R D Scheyer; V L Ouellette
Journal:  JAMA       Date:  1989-06-09       Impact factor: 56.272

7.  Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia.

Authors:  E Diaz; H B Levine; M C Sullivan; M J Sernyak; K A Hawkins; J A Cramer; S W Woods
Journal:  J Psychiatry Neurosci       Date:  2001-09       Impact factor: 6.186

8.  Assessing the utility of a community pharmacy refill record as a measure of adherence and viral load response in patients infected with human immunodeficiency virus.

Authors:  John F Inciardi; Andrew L Leeds
Journal:  Pharmacotherapy       Date:  2005-06       Impact factor: 4.705

9.  A comparison of the content-, construct- and predictive validity of the cigarette dependence scale and the Fagerström test for nicotine dependence.

Authors:  Jean-François Etter
Journal:  Drug Alcohol Depend       Date:  2005-03-07       Impact factor: 4.492

10.  Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries.

Authors:  Glenn J Wagner
Journal:  AIDS Patient Care STDS       Date:  2002-12       Impact factor: 5.078

View more
  149 in total

Review 1.  A proposal for quality standards for measuring medication adherence in research.

Authors:  Ann Bartley Williams; K Rivet Amico; Carol Bova; Julie A Womack
Journal:  AIDS Behav       Date:  2013-01

Review 2.  Self-report measures of medication adherence behavior: recommendations on optimal use.

Authors:  Michael J Stirratt; Jacqueline Dunbar-Jacob; Heidi M Crane; Jane M Simoni; Susan Czajkowski; Marisa E Hilliard; James E Aikens; Christine M Hunter; Dawn I Velligan; Kristen Huntley; Gbenga Ogedegbe; Cynthia S Rand; Eleanor Schron; Wendy J Nilsen
Journal:  Transl Behav Med       Date:  2015-07-09       Impact factor: 3.046

3.  Comparison of antiretroviral adherence questions.

Authors:  Karina M Berg; Ira B Wilson; Xuan Li; Julia H Arnsten
Journal:  AIDS Behav       Date:  2012-02

4.  Behavioral intervention improves treatment outcomes among HIV-infected individuals who have delayed, declined, or discontinued antiretroviral therapy: a randomized controlled trial of a novel intervention.

Authors:  Marya Gwadz; Charles M Cleland; Elizabeth Applegate; Mindy Belkin; Monica Gandhi; Nadim Salomon; Angela Banfield; Noelle Leonard; Marion Riedel; Hannah Wolfe; Isaiah Pickens; Kelly Bolger; DeShannon Bowens; David Perlman; Donna Mildvan
Journal:  AIDS Behav       Date:  2015-10

5.  Impact of HIV-Status Disclosure on HIV Viral Load in Pregnant and Postpartum Women on Antiretroviral Therapy.

Authors:  Kirsty Brittain; Claude A Mellins; Robert H Remien; Tamsin K Phillips; Allison Zerbe; Elaine J Abrams; Landon Myer
Journal:  J Acquir Immune Defic Syndr       Date:  2019-08-01       Impact factor: 3.731

6.  Female adherence self-efficacy before and after couple HIV testing and counseling within Malawi's Option B+ program.

Authors:  Austin Wesevich; Mina C Hosseinipour; Carol E Golin; Nuala McGrath; Mercy Tsidya; Limbikani Chimndozi; Nivedita Bhushan; Irving Hoffman; William C Miller; Nora E Rosenberg
Journal:  AIDS Care       Date:  2019-06-25

Review 7.  The relationship between neuropsychological functioning and HAART adherence in HIV-positive adults: a systematic review.

Authors:  Travis I Lovejoy; Julie A Suhr
Journal:  J Behav Med       Date:  2009-03-17

Review 8.  Implementing HIV-1 genotypic resistance testing in antiretroviral therapy programs in Africa: needs, opportunities, and challenges.

Authors:  Richard J Lessells; Ava Avalos; Tulio de Oliveira
Journal:  AIDS Rev       Date:  2013 Oct-Dec       Impact factor: 2.500

9.  Assessment of HIV antiretroviral therapy adherence by measuring drug concentrations in hair among children in rural Uganda.

Authors:  Peter K Olds; Julius P Kiwanuka; Denis Nansera; Yong Huang; Peter Bacchetti; Chengshi Jin; Monica Gandhi; Jessica E Haberer
Journal:  AIDS Care       Date:  2014-12-06

10.  Impact of Asha intervention on stigma among rural Indian women with AIDS.

Authors:  Adeline Nyamathi; Maria Ekstrand; Benissa E Salem; Sanjeev Sinha; Kalyan K Ganguly; Barbara Leake
Journal:  West J Nurs Res       Date:  2013-03-27       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.